+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Dexmethylphenidate"

Attention Deficit Hyperactivity Disorder - Pipeline Insight, 2024 - Product Thumbnail Image

Attention Deficit Hyperactivity Disorder - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
From
From
  • 10 Results (Page 1 of 1)
Loading Indicator

Dexmethylphenidate is a central nervous system stimulant used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy. It is a methylphenidate-based drug, similar to Ritalin, and is available in both immediate-release and extended-release formulations. It is used to improve focus, concentration, and reduce impulsivity and hyperactivity in people with ADHD. It is also used to treat narcolepsy, a sleep disorder characterized by excessive daytime sleepiness. Dexmethylphenidate is part of the larger mental disorders drugs market, which includes medications used to treat a variety of mental health conditions, such as depression, anxiety, bipolar disorder, and schizophrenia. These drugs are used to improve symptoms, reduce the risk of relapse, and improve quality of life. Companies in the dexmethylphenidate market include Shire, Impax Laboratories, Mallinckrodt Pharmaceuticals, and Actavis. Show Less Read more